Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API

Medical Case Reports and Studies

115 ta ish

  1. What is resistant arterial hypertension?

    E. Shalaeva, Franz H. Messerli

    Sharh maqolaBlood Pressure and Hypertension StudiesBlood Pressure20232 iqtibos
    ABI

  2. Palliative care as a part of national cancer control plan in Uzbekistan

    Y. Ziyaev, Mirzagaleb Tillyashaykhov, S.B. Abdujapparov +3

    MaqolaEmpathy and Medical EducationAnnals of Oncology20170 iqtibos
    ABI

  3. Palliative care as a part of national cancer control plan in Uzbekistan – first steps towards the solution

    Y. Ziyaev, Mirzagaleb Tillyashaykhov, A. Yusupbekov +4

    MaqolaEmpathy and Medical EducationAnnals of Oncology20180 iqtibos
    ABI

  4. Kodiyala ondu samskruthika adhyayana

    K. Kumara

    DissertatsiyaMedical Case Reports and StudiesShodhganga20180 iqtibos
    ABI

  5. Ginecologia [2.ed.]

    Manoel João Batista Castello Girão, Geraldo Rodrigues de Lima, Edmund Chada Baracat +2

    KitobMenopause: Health Impacts and TreatmentsManole eBooks20190 iqtibos
    ABI

  6. Peculiarities of the Clinical Course of Chronic Viral Hepatitis C in the Background of End-Stage Chronic Renal Insufficiency

    Firuza Aripkhodjayeva, Rustam Akalayev, Saodat Rashidova +2

    MaqolaHepatitis C virus researchExperimental and Clinical Transplantation20200 iqtibos
    ABI

  7. Features and Course of Epilepsy in the Mountain Desert Regions of The Surkhandara Region

    Y.N. Madjidova, Shokirjon Bakhodirovich Mamatkurbonov

    MaqolaHistory of Medicine StudiesInternational Journal of Medical Science and Clinical Research Studies20210 iqtibos
    ABI

  8. HOW TO ASSESS THE FUNCTIONAL STATE OF THE THYROID GLAND AND WHAT TO DO IN THE SITUATION WHERE THE TESTS ARE INADEQUATE?

    1Yuldashev Nosirdjan Muxamedjanovich, 2Rasulova Moxidil Tursunaliyevna, 2Rayimov Alisher Xoldorovich

    MaqolaThyroid Disorders and TreatmentsZenodo (CERN European Organization for Nuclear Research)20220 iqtibos
    ABI

  9. TESTICLE

    Murodullayev KHumoyun Izzatillo ugli, Azimbekova Sitora Nodirovna

    BoshqaTesticular diseases and treatmentsZenodo (CERN European Organization for Nuclear Research)20220 iqtibos
    ABI

  10. THOUGHTS ABOUT DIABETES

    Kurbanova Nozima Sobirjonovna, Nizomitdinova Zinura Isomiddinovna, Adhamjonova O'ktamkhan Akmalkhan qizi

    MaqolaMedical Case Reports and StudiesZenodo (CERN European Organization for Nuclear Research)20230 iqtibos
    ABI

  11. IMPORTANT ISSUES TO CONSIDER WHEN CONDUCTING RESEARCH IN LABORATORY DIAGNOSTICS

    Ergasheva Sofiya, Rajabboyeva Robiya, Khakimova Asilabonu +2

    MaqolaClinical Laboratory Practices and Quality ControlZenodo (CERN European Organization for Nuclear Research)20230 iqtibos
    ABI

  12. PSIXONKOLOGIYA ETIKASI

    KUCHKOROVA IRODA DONIYOROVNA

    MaqolaCancer and biochemical researchZenodo (CERN European Organization for Nuclear Research)20230 iqtibos
    ABI

  13. Early Detection and Control of Risk Factors for Cardiovascular Diseases in the Aral Region: Experience of Uzbekistan

    H. G. Fozilov, H. H. Ataniyazov, Gulnoz Khamidullaeva +2

    MaqolaBiomarkers in Disease MechanismsKardiologiia20240 iqtibos
    ABI

  14. MICROELEMENT COMPOSITION OF HAIR AND PHYSICAL DEVELOPMENT OF CHILDREN IN THE ARAL REGION

    С.Р. Худайназарова, S.M. Kuryazova

    MaqolaTherapeutic Uses of Natural ElementsInnovations in medicine and pharmacy20240 iqtibos
    ABI

  15. Cardiovascular Diseases in Uzbekistan: Causes, Prevention, and Treatment

    Dostonbek Turg’unboyev

    MaqolaMedical Case Reports and StudiesEuropean Journal of Medical and Health Research20250 iqtibos
    ABI

  16. EVALUATION OF MUMIJO'S EFFECTS ON BLEEDING TIME AND BLOOD LOSS IN EXPERIMENTAL RAT MODELS.

    Egamberdiyev Jasur

    MaqolaHumic Substances and Bio-Organic StudiesZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  17. PATHOGENESIS OF NEUROBLASTOMA DEVELOPMENT IN CHILDREN

    Sur'atova S.Sh.

    MaqolaNeuroblastoma Research and TreatmentsZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  18. PATHOGENESIS OF NEUROBLASTOMA DEVELOPMENT IN CHILDREN

    Sur'atova S.Sh.

    MaqolaNeuroblastoma Research and TreatmentsZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  19. Effective Control And Correction Of The Main Risk Factors Of Hypertonic Disease In The Conditions Of The Primary Line Of Health Care

    Shakhzada S. Gulyamova

    MaqolaMedical Case Reports and StudiesInternational Journal of Medical Sciences And Clinical Research20250 iqtibos
    ABI

  20. MORPHOLOGICAL ASSESSMENT OF AGE-RELATED CHANGES IN THE THYROID GLAND

    Oripova, Nargiza Akhtamovna

    MaqolaThyroid Disorders and TreatmentsZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  21. MORPHOLOGICAL ASSESSMENT OF AGE-RELATED CHANGES IN THE THYROID GLAND

    Oripova, Nargiza Akhtamovna

    MaqolaThyroid Disorders and TreatmentsZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  22. Circulatory System Diseases And Issues In Their Classification

    Aktamov Shokhrukhbek Ulugbek ugli

    MaqolaMedical Case Reports and StudiesTexas Journal of Engineering and Technology20250 iqtibos
    ABI

  23. INTRAKRANIAL BOSIMNING OShIShI: BELGILARI, SABABLARI VA DAVOLASH-PROFILAKTIKASI

    Qarshiyeva Muhabbat, Aburaximova O'g'iloy, Hasanov Dilmurod

    MaqolaNeurological Disorders and TreatmentsZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  24. INTRAKRANIAL BOSIMNING OShIShI: BELGILARI, SABABLARI VA DAVOLASH-PROFILAKTIKASI

    Qarshiyeva Muhabbat, Aburaximova O'g'iloy, Hasanov Dilmurod

    MaqolaNeurological Disorders and TreatmentsZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI

  25. DIAGNOSTIC CRITERIA OF MULTIPLE SCLEROSIS: CURRENT APPROACHES AND CLINICAL SIGNIFICANCE

    Ilyosbek Yaqubov

    MaqolaMultiple Sclerosis Research StudiesZenodo (CERN European Organization for Nuclear Research)20250 iqtibos
    ABI